PD‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐PD‐1/PD‐L1 clinical trials
暂无分享,去创建一个
J. Madore | J. Wilmott | R. Scolyer | P. Hersey | J. Yearley | R. Kefford | G. Long | A. Menzies | H. Kakavand | R. Vilain | J. Hyman | J. Thompson